Market Cap 10.95M
Revenue (ttm) 0.00
Net Income (ttm) -14.50M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 19,800
Avg Vol 100,204
Day's Range N/A - N/A
Shares Out 3.92M
Stochastic %K 10%
Beta 2.13
Analysts Strong Sell
Price Target $21.50

Company Profile

Imunon, Inc., a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines. The company's lead clinical program is IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non...

Industry: Biotechnology
Sector: Healthcare
Phone: 609 896 9100
Website: imunon.com
Address:
997 Lenox Drive, Suite 100, Lawrenceville, United States
ConcernedCitizen23
ConcernedCitizen23 Apr. 25 at 9:27 PM
$IMNN quiet here is very good. Separate phase 2 at the most prestigious hospitals wrapping up and phase 3 well underway. I see a lot of value here and that will be apparent. Btw they reported 24month longevity advantage in maintenance patients. If you don’t realize that means $$$ you’re a moron.
1 · Reply
LKDOG
LKDOG Apr. 24 at 11:35 AM
$IMNN https://stocktwits.com/LKDOG/message/651258534 For what it is worth … Good luck
0 · Reply
LongBallBarn
LongBallBarn Apr. 24 at 11:30 AM
$OGN $VTVT $EPOW $IMNN Huge adds huge gains
0 · Reply
LKDOG
LKDOG Apr. 24 at 11:19 AM
0 · Reply
LKDOG
LKDOG Apr. 22 at 7:19 PM
$IMNN 🤬 WTF ? Any negative information presented …. ?
1 · Reply
LKDOG
LKDOG Apr. 20 at 8:10 PM
$IMNN Surprised how quite it has been….
0 · Reply
ConcernedCitizen23
ConcernedCitizen23 Apr. 16 at 11:50 AM
$IMNN the executive team is excellent at running the clinical trials but not great at doing PR that gets real eye balls. I expect this process to leapfrog once a celebrity or family of a celebrity/hedge fund manager is personally effected and sings the praises of Imunon!
0 · Reply
RaKa82
RaKa82 Apr. 15 at 3:51 PM
$IMNN this stock is SO undervalued that even the shorts won’t touch it as they know there’s no meat left on the bones. SI has dropped each reporting period this year. Any good news and the dogs are off
0 · Reply
RaKa82
RaKa82 Apr. 15 at 2:44 AM
$IMNN once some data starts trickling in, this company will be gone, acquired for a few hundred mills. This poater makea a good point about how easily this can be bought up
1 · Reply
ConcernedCitizen23
ConcernedCitizen23 Apr. 14 at 1:05 PM
$IMNN they just reported final data on phase 2 and are now active with phase 3. There’s another phase 2 trial at Johns Hopkins, sloan Kettering, md Anderson and Oklahoma! News is that the John Hopkins data is complete early! Look at the screen shot from http://clinicaltrials.org
1 · Reply
Latest News on IMNN
Imunon Earnings Call Transcript: Q4 2025

Mar 31, 2026, 11:00 AM EDT - 25 days ago

Imunon Earnings Call Transcript: Q4 2025


Imunon Earnings Call Transcript: Q3 2025

Nov 13, 2025, 11:00 AM EST - 5 months ago

Imunon Earnings Call Transcript: Q3 2025


Imunon Earnings Call Transcript: Q2 2025

Aug 5, 2025, 11:00 AM EDT - 9 months ago

Imunon Earnings Call Transcript: Q2 2025


IMUNON Announces Stock Dividend Boosting Shareholder Value

Jul 28, 2025, 8:05 AM EDT - 9 months ago

IMUNON Announces Stock Dividend Boosting Shareholder Value


IMUNON Announces Reverse Stock Split

Jul 23, 2025, 8:00 AM EDT - 9 months ago

IMUNON Announces Reverse Stock Split


Imunon Transcript: Life Sciences Investor Forum

Jun 12, 2025, 11:30 AM EDT - 11 months ago

Imunon Transcript: Life Sciences Investor Forum


Imunon Earnings Call Transcript: Q1 2025

May 12, 2025, 11:00 AM EDT - 1 year ago

Imunon Earnings Call Transcript: Q1 2025


Imunon Earnings Call Transcript: Q4 2024

Feb 27, 2025, 11:00 AM EST - 1 year ago

Imunon Earnings Call Transcript: Q4 2024


IMUNON Appoints Douglas V. Faller, M.D.

Feb 10, 2025, 8:05 AM EST - 1 year ago

IMUNON Appoints Douglas V. Faller, M.D.


Imunon Earnings Call Transcript: Q3 2024

Nov 7, 2024, 11:00 AM EST - 1 year ago

Imunon Earnings Call Transcript: Q3 2024


Imunon Earnings Call Transcript: Q2 2024

Aug 14, 2024, 11:00 AM EDT - 1 year ago

Imunon Earnings Call Transcript: Q2 2024


Imunon Transcript: Study Result

Jul 30, 2024, 8:30 AM EDT - 1 year ago

Imunon Transcript: Study Result


Imunon Earnings Call Transcript: Q1 2024

May 13, 2024, 11:00 AM EDT - 2 years ago

Imunon Earnings Call Transcript: Q1 2024


Imunon Earnings Call Transcript: Q4 2023

Mar 28, 2024, 10:00 AM EDT - 2 years ago

Imunon Earnings Call Transcript: Q4 2023


Imunon Earnings Call Transcript: Q3 2023

Nov 14, 2023, 10:00 AM EST - 2 years ago

Imunon Earnings Call Transcript: Q3 2023


Imunon Transcript: R&D Day 2023

Sep 14, 2023, 4:00 PM EDT - 2 years ago

Imunon Transcript: R&D Day 2023


Imunon Earnings Call Transcript: Q2 2023

Aug 10, 2023, 11:00 AM EDT - 2 years ago

Imunon Earnings Call Transcript: Q2 2023


Imunon Earnings Call Transcript: Q1 2023

May 11, 2023, 11:00 AM EDT - 3 years ago

Imunon Earnings Call Transcript: Q1 2023


Imunon Earnings Call Transcript: Q4 2022

Mar 30, 2023, 11:00 AM EDT - 3 years ago

Imunon Earnings Call Transcript: Q4 2022


Imunon Earnings Call Transcript: Q3 2022

Nov 14, 2022, 11:00 AM EST - 3 years ago

Imunon Earnings Call Transcript: Q3 2022


Imunon Earnings Call Transcript: Q2 2022

Aug 15, 2022, 7:45 AM EDT - 4 years ago

Imunon Earnings Call Transcript: Q2 2022


Imunon Earnings Call Transcript: Q1 2022

May 16, 2022, 8:55 AM EDT - 4 years ago

Imunon Earnings Call Transcript: Q1 2022


ConcernedCitizen23
ConcernedCitizen23 Apr. 25 at 9:27 PM
$IMNN quiet here is very good. Separate phase 2 at the most prestigious hospitals wrapping up and phase 3 well underway. I see a lot of value here and that will be apparent. Btw they reported 24month longevity advantage in maintenance patients. If you don’t realize that means $$$ you’re a moron.
1 · Reply
LKDOG
LKDOG Apr. 24 at 11:35 AM
$IMNN https://stocktwits.com/LKDOG/message/651258534 For what it is worth … Good luck
0 · Reply
LongBallBarn
LongBallBarn Apr. 24 at 11:30 AM
$OGN $VTVT $EPOW $IMNN Huge adds huge gains
0 · Reply
LKDOG
LKDOG Apr. 24 at 11:19 AM
0 · Reply
LKDOG
LKDOG Apr. 22 at 7:19 PM
$IMNN 🤬 WTF ? Any negative information presented …. ?
1 · Reply
LKDOG
LKDOG Apr. 20 at 8:10 PM
$IMNN Surprised how quite it has been….
0 · Reply
ConcernedCitizen23
ConcernedCitizen23 Apr. 16 at 11:50 AM
$IMNN the executive team is excellent at running the clinical trials but not great at doing PR that gets real eye balls. I expect this process to leapfrog once a celebrity or family of a celebrity/hedge fund manager is personally effected and sings the praises of Imunon!
0 · Reply
RaKa82
RaKa82 Apr. 15 at 3:51 PM
$IMNN this stock is SO undervalued that even the shorts won’t touch it as they know there’s no meat left on the bones. SI has dropped each reporting period this year. Any good news and the dogs are off
0 · Reply
RaKa82
RaKa82 Apr. 15 at 2:44 AM
$IMNN once some data starts trickling in, this company will be gone, acquired for a few hundred mills. This poater makea a good point about how easily this can be bought up
1 · Reply
ConcernedCitizen23
ConcernedCitizen23 Apr. 14 at 1:05 PM
$IMNN they just reported final data on phase 2 and are now active with phase 3. There’s another phase 2 trial at Johns Hopkins, sloan Kettering, md Anderson and Oklahoma! News is that the John Hopkins data is complete early! Look at the screen shot from http://clinicaltrials.org
1 · Reply
bxp2390
bxp2390 Apr. 13 at 1:54 PM
$IMNN This seems to be making a case for high response rates with a durable follow-on monotherapy phase in biomarker-selected relapsed patients. Different from Imunon and if both succeed then theoretically a future patient could receive both across their disease course. Just IMO, but Abbvie's interest in Ovarian cancer treatments can bode well. I am sure they are aware of what Imunon is doing.
2 · Reply
ConcernedCitizen23
ConcernedCitizen23 Apr. 12 at 11:22 PM
$IMNN $ABBV study had half the pts on PARP just like Imunon did. Also Imunon had much better results. Most underrated biotech out there 50x is my target price https://news.abbvie.com/2026-04-12-AbbVie-Showcases-Late-Breaking-Phase-2-Data-for-Mirvetuximab-Soravtansine-gynx-ELAHERE-R-in-Platinum-Sensitive-Ovarian-Cancer-PSOC-at-SGO-2026
1 · Reply
V9RDPUMA
V9RDPUMA Apr. 12 at 12:12 PM
$IMNN Does abbvie’s late breaking ovarian cancer phase 2 results announced today hurt or help imnn?
3 · Reply
jjegglie
jjegglie Apr. 12 at 12:56 AM
$IMNN Weekend reminder that celsion shares are down 99.99999% from all time highs and has never produced a single penny of revenue or developed a product. The company exists to enrich management through continuous share issuance.
0 · Reply
jjegglie
jjegglie Apr. 9 at 8:07 PM
$IMNN 27% dilution reflecting in shares outstanding today on etrade. About 7 weeks of funding. More dilution will follow. And soon.
0 · Reply
LKDOG
LKDOG Apr. 9 at 5:05 PM
$IMNN Crickets ….
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 9 at 4:32 PM
$IMNN RSI: 60.87, MACD: -0.0097 Vol: 0.15, MA20: 2.98, MA50: 3.14 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
bxp2390
bxp2390 Apr. 8 at 3:31 AM
$IMNN Hmm, looks like the old points that this is the same as the old Celsion trial have been quietly dropped, only now to bring up accusations that the new CEO was hired to manipulate data (a serious allegation with absolutely no basis in fact i must stress). I'll take that as progress. You still have time to buy and hold, the market holds no grudges based on past positions.
1 · Reply
jjegglie
jjegglie Apr. 7 at 8:18 PM
$IMNN They hired a bunch of bums, washouts and yes men...... all rejects from other companies. And the only two names that matter are Michael Turd-ugno and Sleazy Statborg. He still very much runs the show and Statborg is a statistician hired to manipulate the atrocious p2 data. You mention butter coated doxorubicin, but fail to mention it's 3 time phase 3 failure (under the turd) that kept management paid for over a decade, and aren't bright enough to recognize the nexus to the exact same boilerplate scam that they're running with this new trash.
0 · Reply
ConcernedCitizen23
ConcernedCitizen23 Apr. 5 at 5:08 PM
$IMNN now getting one new patient per phase 3 site. They have 7 sites already. This thing will snowball fast. These doctors and patients talk. Just wait until word gets out you can live 2 years longer if you go on the treatment and stay on the treatment.
1 · Reply
ConcernedCitizen23
ConcernedCitizen23 Apr. 3 at 4:17 PM
$IMNN I’ve always said this is an easy 30-50x and fully believe it ! 2 extra years of life in phase 2?!? Phase 3 will blow the doors off!
2 · Reply
RaKa82
RaKa82 Apr. 2 at 8:41 PM
$IMNN relatively strong this week. Outperformed XBI and broader markets.
0 · Reply